German Federal Institute for Occupational Safety and Health (BAuA) has published its annual overview on dangerous technical products: Thus, both the number of reported dangerous products and the published product... read more →
In the new edition of its biosimilars leaflet, he Drug Commission of the German Medical Association (AkdÄ) informs on the use and the safety profile of biosimilars. Additionally, the Drug... read more →
According to the first report of European Medicines Agency EMA, the existing data do not show any relationship between the vaccination with the Covid-19 vaccine Tozinameran/Comirnaty by Biontech and Pfizer... read more →
Creating a COVID-19 Response Group working within the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), the European Medicines Agency (EMA) has strengthened the mandate amid the current pandemic.... read more →
Stricken US aircraft maker Boeing has resumed the production of its model 737 Max after it had been grounded after two air crashes. Production will initially start on a lower... read more →
A new study by ECC Cologne named “Adventure, Thrill or Risk? Why Customers Order at Wish and Co.” suggests that low prices are more important than quick delivery for many... read more →
German Technical University of Aschaffenburg introduces its distance study program Reliability Engineering (M.Eng.): (Electro-)technical systems become more and more complex and both manufacturers and suppliers are obliged to prove their... read more →
With Chinese State Council reporting that authorities seized more than 80 million counterfeit or faulty masks and 370,000 defective or fake disinfectants and other anti-coronavirus products in one month alone,... read more →
The problems of the Japanese airbag supplier Takata now led to recalls of more than 20-year-old cars. The European dealers alone had to deal with nearly 200,000 vehicles, a spokesman... read more →
With the preparation and application of Leuprorelin-containing medicinal products being complicated and error-prone, the Pharmacovigilance Risk Assessment Committee (PRAC) within the European Medicines Agency recommends new measures to avoid application... read more →